FDA Forges Ahead On Reform Of Drug Ads' Risk Disclosures
The U.S. Food and Drug Administration on Monday said it will re-evaluate how prescription drug risks are disclosed in television advertisements, a significant endeavor that's being closely watched by Big Pharma...To view the full article, register now.
Already a subscriber? Click here to view full article